These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15746245)

  • 1. Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice.
    Lapenta C; Spada M; Santini SM; Racca S; Dorigatti F; Poli G; Belardelli F; Alfano M
    Int Immunol; 2005 Apr; 17(4):469-75. PubMed ID: 15746245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
    Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
    J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
    Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
    Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis toxin and its binding unit inhibit HIV-1 infection of human cervical tissue and macrophages involving a CD14 pathway.
    Hu Q; Younson J; Griffin GE; Kelly C; Shattock RJ
    J Infect Dis; 2006 Dec; 194(11):1547-56. PubMed ID: 17083039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-4-transgenic hu-PBL-SCID mice: a model for the screening of antiviral drugs and immunotherapeutic agents against X4 HIV-1 viruses.
    Okuma K; Tanaka R; Ogura T; Ito M; Kumakura S; Yanaka M; Nishizawa M; Sugiura W; Yamamoto N; Tanaka Y
    J Infect Dis; 2008 Jan; 197(1):134-41. PubMed ID: 18171296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SCID-hu mice: a model for studying disseminated HIV infection.
    Goldstein H; Pettoello-Mantovani M; Katopodis NF; Kim A; Yurasov S; Kollmann TR
    Semin Immunol; 1996 Aug; 8(4):223-31. PubMed ID: 8883145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of HIV-1 epitopes that induce the synthesis of a R5 HIV-1 suppression factor by human CD4+ T cells isolated from HIV-1 immunized hu-PBL SCID mice.
    Yoshida A; Tanaka R; Kodama A; Yamamoto N; Ansari AA; Tanaka Y
    Clin Dev Immunol; 2005 Dec; 12(4):235-42. PubMed ID: 16584108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-induced human B-cell lymphomas in SCID mice reconstituted with human peripheral blood leukocytes.
    Mosier DE; Picchio GR; Baird SM; Kobayashi R; Kipps TJ
    Cancer Res; 1992 Oct; 52(19 Suppl):5552s-5553s. PubMed ID: 1327510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent anti-R5 human immunodeficiency virus type 1 effects of a CCR5 antagonist, AK602/ONO4128/GW873140, in a novel human peripheral blood mononuclear cell nonobese diabetic-SCID, interleukin-2 receptor gamma-chain-knocked-out AIDS mouse model.
    Nakata H; Maeda K; Miyakawa T; Shibayama S; Matsuo M; Takaoka Y; Ito M; Koyanagi Y; Mitsuya H
    J Virol; 2005 Feb; 79(4):2087-96. PubMed ID: 15681411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining antibody protection against HIV-1 transmission in Hu-PBL-SCID mice.
    Koup RA; Safrit JT; Weir R; Gauduin MC
    Semin Immunol; 1996 Aug; 8(4):263-8. PubMed ID: 8883150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrahydrocannabinol suppresses immune function and enhances HIV replication in the huPBL-SCID mouse.
    Roth MD; Tashkin DP; Whittaker KM; Choi R; Baldwin GC
    Life Sci; 2005 Aug; 77(14):1711-22. PubMed ID: 15964028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloned human CD8+ cytotoxic T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-1 infection by an HLA-unrestricted mechanism.
    van Kuyk R; Torbett BE; Gulizia RJ; Leath S; Mosier DE; Koenig S
    J Immunol; 1994 Nov; 153(10):4826-33. PubMed ID: 7963548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EBV-induced human B cell lymphomas in hu-PBL-SCID mice.
    Mosier DE; Picchio GR; Kirven MB; Garnier JL; Torbett BE; Baird SM; Kobayashi R; Kipps TJ
    AIDS Res Hum Retroviruses; 1992 May; 8(5):735-40. PubMed ID: 1325170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model.
    Cao T; Lazdina U; Desombere I; Vanlandschoot P; Milich DR; Sällberg M; Leroux-Roels G
    J Virol; 2001 Jul; 75(14):6359-66. PubMed ID: 11413302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative assessment of human immunodeficiency virus type 1 replication in human xenografts of acutely infected Hu-PBL-SCID mice.
    Koup RA; Hesselton RM; Safrit JT; Somasundaran M; Sullivan JL
    AIDS Res Hum Retroviruses; 1994 Mar; 10(3):279-84. PubMed ID: 8018388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha.
    Lapenta C; Santini SM; Logozzi M; Spada M; Andreotti M; Di Pucchio T; Parlato S; Belardelli F
    J Exp Med; 2003 Jul; 198(2):361-7. PubMed ID: 12874266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection.
    Fais S; Lapenta C; Santini SM; Spada M; Parlato S; Logozzi M; Rizza P; Belardelli F
    J Virol; 1999 Aug; 73(8):6453-9. PubMed ID: 10400739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice.
    Garaci E; Aquaro S; Lapenta C; Amendola A; Spada M; Covaceuszach S; Perno CF; Belardelli F
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8927-32. PubMed ID: 12853577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain.
    Koyanagi Y; Tanaka Y; Kira J; Ito M; Hioki K; Misawa N; Kawano Y; Yamasaki K; Tanaka R; Suzuki Y; Ueyama Y; Terada E; Tanaka T; Miyasaka M; Kobayashi T; Kumazawa Y; Yamamoto N
    J Virol; 1997 Mar; 71(3):2417-24. PubMed ID: 9032379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes.
    Roth MD; Tashkin DP; Choi R; Jamieson BD; Zack JA; Baldwin GC
    J Infect Dis; 2002 Mar; 185(5):701-5. PubMed ID: 11865430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.